Liquid biopsy assessing the blood or urine samples may help monitor the effectiveness of cancer therapy for the initial phase of colorectal cancer metastasis.
Assessment of circulating tumor cells at first clinic visit predicted relapse of stage III Melanoma within 6 months.
In patients with locally advanced rectal cancer, ctDNA a form of liquid biopsy was found to be more accurate technique to monitor treatment response, stated new study.
Simple urine tests with routine imaging could speed up adrenal cancer diagnosis, improve the patient's prognosis, decrease the need for invasive diagnostic procedures, report a new study.